What a pleasure it was to meet Donghoon Shin! His passion and desire to learn from patient advocates was genuine and impressive. The future of #lungcancer research is bright😎
#LCSM #EGFR

Congrats Donghoon Shin on receiving an honorable mention at the @EGFRSummit Your research and passion for the field are truly impressive #ProudMentor

Huge shoutout to @EGFRResisters for giving trainees a platform to showcase their work! #LCSM 🙌🏼 @jillfeldman4.bsky.social

FDA approves durvalumab for limited-stage small cell lung cancer On December 4, 2024, the Food and Drug Administration approved durvalumab (Imfinzi, AstraZeneca) for limited-stage small cell lung cancer (LS-SCLC).

The durva approval for limited stage small cell lung cancer made my day

I had a throughout conversation with my patient just two days ago, and now it’s been approved!

www.fda.gov/drugs/resour...

Just finished my first week of inpatient service as an attending!

I’m deeply grateful for the growth of my professional career and for the patients who have been a part of this journey. #IMG #MedEd

Updated treatment algorithms for breast cancer now include adjuvant ribociclib and inavolisib, along with key trial names. Thrilled to see we're truly running out of space in HR+ disease—progress is here, with much more to come for all breast cancer subtypes!

📢 The @ASCO released updated living guidelines for treating stage IV #NSCLC with driver alterations! ascopubs.org/doi/10.1200/....

This is no easy feat, but it was an honor to work alongside exceptional experts dedicated to providing the most up-to-date, evidence-based guidance.
#LCSM #LCAM

Adopting Broader Clinical Trial Eligibility in Lung Cancer With Brain Mets, Leptomeningeal Disease Ivy Riano, MD, of Dartmouth Geisel School of Medicine, discusses the adoption of broader clinical trial eligibility in lung cancer, specifically for those with brain metastases or leptomeningeal disea...

We are excited to be Shining the Spotlight on the work of Rising 🌟, Dr. Ivy Riano of Dartmouth as she discusses Broadened Eligibility Criteria in Lung Cancer Clinical Trials for Patients w Brain Metastasis on MedNews Week Medical Spotlight in partnership w OncLive.

www.onclive.com/view/adoptin...